Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis.
Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis.
复制标题
DOI:
10.1038/s41598-022-16754-7
复制
发表时间:
2022-08-05
影响因子:
4.6
通讯作者:
Pers, Tune H.
中科院分区:
文献类型:
--
作者:
Fred, Rikard G.;Pedersen, Julie Steen;Thompson, Jonatan J.;Lee, Julie;Timshel, Pascal N.;Stender, Stefan;Rygg, Marte Opseth;Gluud, Lise Lotte;Kristiansen, Viggo Bjerregaard;Bendtsen, Flemming;Hansen, Torben;Pers, Tune H.
The aim of this study is to characterize cell type-specific transcriptional signatures in non-alcoholic steatohepatitis (NASH) to improve our understanding of the disease. We performed single-cell RNA sequencing on liver biopsies from 10 patients with NASH. We applied weighted gene co-expression network analysis and validated our findings using a publicly available RNA sequencing data set derived from 160 patients with non-alcoholic fatty liver disease (NAFLD) and 24 controls with normal liver histology. Our study provides a comprehensive single-cell analysis of NASH pathology in humans, describing 19,627 single-cell transcriptomes from biopsy-proven NASH patients. Our data suggest that the previous notion of ”NASH-associated macrophages” can be explained by an up-regulation of normally existing subpopulations of liver macrophages. Similarly, we describe two distinct populations of activated hepatic stellate cells, associated with the level of fibrosis. Finally, we find that the expression of several circulating markers of NAFLD are co-regulated in hepatocytes together with predicted effector genes from NAFLD genome-wide association studies (GWAS), coupled to abnormalities in the complement system. In sum, our single-cell transcriptomic data set provides insights into novel cell type-specific and general biological processes associated with inflammation and fibrosis, emphasizing the importance of studying cell type-specific biological processes in human NASH.
登录
查看更多内容
影响因子:
64.8
作者:
Halpern KB;Shenhav R;Matcovitch-Natan O;Toth B;Lemze D;Golan M;Massasa EE;Baydatch S;Landen S;Moor AE;Brandis A;Giladi A;Avihail AS;David E;Amit I;Itzkovitz S
通讯作者:
Itzkovitz S
DOI:
10.1002/hep.31215
发表时间:
2020-12
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
Terkelsen MK;Bendixen SM;Hansen D;Scott EAH;Moeller AF;Nielsen R;Mandrup S;Schlosser A;Andersen TL;Sorensen GL;Krag A;Natarajan KN;Detlefsen S;Dimke H;Ravnskjaer K
通讯作者:
Ravnskjaer K
影响因子:
16.6
作者:
MacParland SA;Liu JC;Ma XZ;Innes BT;Bartczak AM;Gage BK;Manuel J;Khuu N;Echeverri J;Linares I;Gupta R;Cheng ML;Liu LY;Camat D;Chung SW;Seliga RK;Shao Z;Lee E;Ogawa S;Ogawa M;Wilson MD;Fish JE;Selzner M;Ghanekar A;Grant D;Greig P;Sapisochin G;Selzner N;Winegarden N;Adeyi O;Keller G;Bader GD;McGilvray ID
通讯作者:
McGilvray ID
影响因子:
24.5
作者:
Krenkel, Oliver;Hundertmark, Jana;Tacke, Frank
通讯作者:
Tacke, Frank
影响因子:
4.1
作者:
ARENZANA, N;DECORDOBA, SR;REYCAMPOS, J
通讯作者:
REYCAMPOS, J